In diagnosing and managing these patients, ImmunoCAP ISAC can help you in several ways:
- Shed light on the real sensitization profile of multisensitized patients.
- Reveal potential risk for severe food-related reactions.
- Identify the IgE antibody profile in patients with unsatisfactory response to treatment.
Thanks to the cross-reacting proteins ImmunoCAP ISAC can give you information on hundreds of allergen sources in addition to the 51 sources the proteins are derived from.
ImmunoCAP ISAC can also reveal unexpected sensitizations or help you rule out allergy by delivering IgE results for a broad spectrum of allergens.
In up to 9 out of 10 multisensitized patients ImmunoCAP ISAC has shown to provide refined useful information.
As a result, effective and optimized management can be started earlier, which in turn leads to improved patient health and quality of life.